Quantcast

Latest Cirrhosis Stories

2014-07-21 04:21:46

Group of Women State Legislators Also Urges Baby Boomers & Other At-Risk Americans to Get Screened for Hepatitis C WASHINGTON, July 21, 2014 /PRNewswire-iReach/ -- Women In Government, a national nonprofit organization that empowers and mobilizes all women legislators to effect sound policy, today recognized World Hepatitis Day by urging state and federal lawmakers to enact policies that help address the nationwide hepatitis C epidemic. Women In Government also encouraged baby...

2014-07-08 23:14:58

GI Supply, the maker of Spot Endoscopic Tattoo, developed an innovative medical device that dramatically streamlines paracentesis, benefiting both clinicians and patients suffering from ascites. The RenovaRP Paracentesis Pump removes ascitic fluid simply, safely, and quickly with an automatic, more cost-efficient system. Camp Hill, PA (PRWEB) July 08, 2014 GI Supply announces the availability of the RenovaRP Paracentesis Pump, the next-generation of paracentesis equipment. The RenovaRP is...

2014-07-01 16:29:45

NY Times Article Brings Attention to Dangerous Lifestyle Related Epidemic and Suggests Critical Need for Therapy DENVER, July 1, 2014 /PRNewswire/ -- A recent New York Times article ("Threat Grows from Liver Illness Tied to Obesity", June 13 2014) alerting millions to the growing prevalence and seriousness of fatty liver disease revealed a stark and very concerning reality about therapeutic options. There are currently no drugs approved for either NAFLD (nonalcoholic fatty liver...

2014-06-24 08:25:25

BEERSE, Belgium, June 24, 2014 /PRNewswire/ -- New report calls on governments to play their part and improve surveillance, screening and diagnosis of hepatitis C worldwide 'Tackling hepatitis C: Moving towards an integrated policy approach', a report published by The Economist Intelligence Unit (EIU) today reveals that many countries around the world have been slow to respond with national policies on hepatitis C despite recent government...

2014-06-10 13:01:37

Henry Ford Health System Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC). That was the finding of a study published in the May issue of Clinical Gastroenterology and Hepatology. Investigators from Henry Ford Health System in Detroit, Geisinger Health System in Danville, Pa., and Kaiser Permanente in Honolulu, Hawaii and Portland, Ore. participated in...

2014-05-24 23:01:08

Liver Cirrhosis Bible & Ezra Protocol, designed by Debrea Elkin that claims to provide people with helpful tips to treat liver cirrhosis disease quickly. The website hynguyenblog.com has published a full Liver Cirrhosis Bible & Ezra Protocol review to show whether this method is reliable or not. New York, NY (PRWEB) May 24, 2014 Liver Cirrhosis Bible & Ezra Protocol is a new method created for those that desire to treat liver cirrhosis disease at home without using drugs or...

2014-05-20 23:18:15

In its May 2014 survey, polyDNA found that 36% of respondents wanted to know what complications can arise from a hepatitis B infection. polyDNA reviews the literature, and recommends Gene-Eden-VIR and Novirin, which have a formula proven to reduce viral symptoms in two post-marketing clinical studies. Rochester, NY (PRWEB) May 20, 2014 In polyDNA’s latest survey, 36% of participants wanted to know what complications can arise from a hepatitis B infection. The answer is that a long-term,...

2014-05-12 08:31:08

DUBLIN and SAN DIEGO, May 12, 2014 /PRNewswire/ -- - Acquisition of Lumena Pharmaceuticals, a biopharmaceutical company with late stage rare disease pipeline assets - Adds to Shire's rare diseases portfolio and leverages this expertise, and is a perfect combination with Shire's already strong Gastrointestinal (GI) presence - Adds LUM001 in Phase 2 development for four rare and devastating hepatic diseases, two...

2014-05-09 08:26:09

CAMEO Phase 2 Clinical Trial of LUM001 Now Enrolling Adults with Primary Sclerosing Cholangitis SAN DIEGO, May 9, 2014 /PRNewswire/ -- Lumena Pharmaceuticals (Lumena), a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, today announced the dosing of the first patient in the INDIGO Phase 2 clinical trial of its lead drug candidate, LUM001, in children with progressive...

2014-05-07 08:32:30

-- Filing Includes Data from Treatment-Naive Patients with Advanced Fibrosis and Null Responders with All Stages of Liver Fibrosis -- RARITAN, N.J., May 7, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO(TM) in the United States, in combination with the nucleotide analog NS5B polymerase...


Latest Cirrhosis Reference Libraries

Hepatitis B
2013-02-25 09:11:23

Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...

45_36624a455e3cd9a4152b7670308f0ffa
2011-01-20 19:14:56

Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...

More Articles (2 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related